Skip to main content

Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)

CBE ID
0070
1.4 Project
Endorsed
Endorsement Status
1.1 New or Maintenance
E&M Cycle
Is Under Review
No
Next Planned Maintenance Review
Cardiovascular Spring 2025
1.3 Measure Description

Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12-month period who also have a prior MI or a current or prior LVEF <40% who were prescribed beta-blocker therapy

        • 1.14 Numerator

          Patients who were prescribed beta-blocker therapy

        • 1.15 Denominator

          All patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12-month period who also have a prior (within the past 3 years) MI or a current or prior LVEF < 40%

        • Exclusions

          Denominator Exceptions:
          Documentation of medical reason(s) for not prescribing beta-blocker therapy (e.g., allergy, intolerance, other medical reasons).

          Documentation of patient reason(s) for not prescribing beta-blocker therapy (e.g., patient declined, other patient reasons).

          Documentation of system reason(s) for not prescribing beta-blocker therapy (e.g., other reasons attributable to the health care system).

        • Most Recent Endorsement Activity
          Endorsed Cardiovascular Spring Cycle 2019
          Initial Endorsement
          Last Updated
        • Steward Organization Email
          Steward Organization Copyright

          Copyright 2019 American College of Cardiology, American Heart Association and American Medical Association. All Rights Reserved.